Brief: AFT Pharmaceuticals Says Continue To Expect To Declare A Dividend For FY24
16/02/2024 01:51
Feb 16 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* CONTINUES TO EXPECT TO DECLARE A DIVIDEND FOR FY24
* UPDATES OPERATING PROFIT GUIDANCE TO NZ$23M TO NZ$25M FOR
FY
* REMAIN CONFIDENT OF PROSPECTS, VALUE OF INVESTING THROUGH
SHORT
TERM SWINGS IN AUSTRALASIA
Source text for Eikon: ID:n426277-2
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV